Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-23

Clinical Trial Update: Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Balanced Salt Solution to 0.9% saline for prevention of contrast-induced acute kidney injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acute Kidney Injury, Renal Insufficiency, Chronic | Phase 3 | Status: COMPLETED